BPC-157/TB-500 20mg
Product Information
Label / Documentation
Verify Amino Research product information and COA documentation through the Amino Research verification page at aminoresearch.net.
BPC-157/TB-500 20mg
BPC-157 / TB-500 20mg is a two-component catalog blend. Published preclinical work has examined BPC-157 in rat tendon explants and cultured fibroblasts. Separate related literature has examined thymosin beta-4 in rat wound and keratinocyte-migration models; that literature does not establish identity or equivalence for the TB-500 catalog component.
The cited sources concern separate experimental systems, not this combination product. They do not establish combined effects, safety, efficacy, an approved indication, or suitability for human or animal use. This material is supplied only for laboratory research, with no dosing or administration guidance.
Documentation note: The report provides separate tested-content and purity results for BPC-157 and TB-500 plus one shared blend endotoxin result. No aggregate purity or tested-content total is reported or inferred.
Research sources
- Chang et al.: BPC-157 in tendon explants and fibroblasts — rat tendon explants, cultured fibroblasts, migration, survival, and signaling assays.
- Malinda et al.: thymosin beta-4 in rat and keratinocyte models — related thymosin beta-4 research; not evidence of TB-500 identity or blend effects.
Documentation and related records
Documentation status: Purity + Endotoxin COA.
Review the current BPC-157/TB-500 20mg documentation for lot HEL-4339222, the testing and COA guidance, and the Research Use Only compliance information. For adjacent catalog records, see BPC-157 10mg, TB-500 10mg, BPC-157/TB-500 10mg. These links support catalog navigation and do not imply equivalence or use.
BPC-157/TB-500 20mg — Specifications
Testing & documentation for BPC-157/TB-500 20mg
The current combined third-party report identifies BPC-157/TB-500 20mg for lot HEL-4339222 and reports tested content and purity separately for each listed component plus one shared endotoxin result. No aggregate component total or purity is inferred; researchers should review the literal component results and documentation note.
Only documented test categories are shown. Where a value is not yet published it is shown as “Available on documentation” or “Pending.”
For laboratory research use only
BPC-157/TB-500 20mg is intended solely for laboratory research use by qualified research professionals. It is not for human or animal consumption and is not intended for diagnostic, therapeutic, or clinical use. No dosing or administration guidance is provided. Researchers are responsible for compliance with all applicable laws and regulations. Review Amino Research compliance and RUO information.
How Amino Research materials are supplied
Purity + Endotoxin COA
Current documentation identifies lot HEL-4339222 for this BPC-157/TB-500 20mg record.
Component-Specific Purity
The current report lists a separate UPLC/MS purity result for each component.
Component Test Results
Labeled content and literal tested-content results are disclosed separately for every component.
RUO Documentation
COA access and clear research-only limitations are linked from this product record.
BPC-157/TB-500 20mg
Add this research-use material to your cart, or review its documentation. Pricing reflects current Amino Research pricing.
BPC-157/TB-500 20mg — FAQ
What research context is available for the BPC-157 and TB-500 blend components?
Separate preclinical studies have examined BPC-157 in rat tendon explants and fibroblasts and thymosin beta-4 in rat wound and keratinocyte-migration models. The thymosin beta-4 literature does not establish TB-500 identity, and neither source establishes effects or an approved use for this combined catalog material.
What does the current BPC-157/TB-500 20mg COA document?
The current combined third-party report for lot HEL-4339222 provides component-specific results: BPC-157 — labeled 10 mg, tested content 9.85 mg, purity 99.36%; TB-500 — labeled 10 mg, tested content 9.85 mg, purity 99.12%. The shared blend endotoxin result is < 0.05 EU/mL. No aggregate purity or tested-content total is inferred. Documentation note: The report provides separate tested-content and purity results for BPC-157 and TB-500 plus one shared blend endotoxin result. No aggregate purity or tested-content total is reported or inferred. Review the complete lot-specific PDF.
How should researchers verify this documentation?
Match the product name and lot on the vial to the report, then review the method, purity, tested content, endotoxin result, and report date. See the testing and COA guidance and the COA Library.
Is BPC-157/TB-500 20mg intended for human or animal use?
No. It is supplied solely for laboratory research use by qualified research professionals. It is not for human or animal consumption and is not intended for diagnostic, therapeutic, or clinical use. No dosing or administration guidance is provided. Review the RUO and compliance information.
Which related Amino Research records can be reviewed?
Researchers can review BPC-157 10mg, TB-500 10mg, BPC-157/TB-500 10mg. These links are provided for catalog navigation, not as equivalence or use claims.
Lab Documentation & Batch Records
Amino Research retains identity, purity, and endotoxin documentation organized by lot, and adds new records as additional batches are tested. The newest report is the current documentation; earlier reports are retained as batch history. Third-party tested. For laboratory research use only.
Research Use Only. Documentation is provided for identity and quality verification for laboratory research use only. Not for human or animal consumption.
